(3aR,4R,7S,7aR)-3-(pyridin-3-yl)-N-(o-tolyl)-4,5,6,7-tetrahydro-4,7-methanobenzo[d]isoxazole-7a(3aH)-carboxamide

ID: ALA5195876

PubChem CID: 168292485

Max Phase: Preclinical

Molecular Formula: C21H21N3O2

Molecular Weight: 347.42

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccccc1NC(=O)[C@]12ON=C(c3cccnc3)[C@H]1[C@@H]1CC[C@H]2C1

Standard InChI:  InChI=1S/C21H21N3O2/c1-13-5-2-3-7-17(13)23-20(25)21-16-9-8-14(11-16)18(21)19(24-26-21)15-6-4-10-22-12-15/h2-7,10,12,14,16,18H,8-9,11H2,1H3,(H,23,25)/t14-,16+,18-,21-/m1/s1

Standard InChI Key:  XRNHAKBGQSAPJY-HRWHDRTOSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
    2.7225    1.0377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8975    1.0377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4869    1.7493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8971    2.4582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7188    2.4582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1288    1.7511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4867    0.3262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6652    0.3262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2584    1.0399    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2506   -0.3827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0670   -0.4743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7352   -0.3661    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.8468   -1.3429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0922   -1.7969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3951   -2.4582    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.9086   -1.8883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3959   -1.2270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2367   -1.0441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7855   -1.6555    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0123   -0.8006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0123    0.0167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2156    0.2646    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7201   -1.2093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7201   -2.0266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4236   -2.4346    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1332   -2.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1332   -1.2097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4253   -0.8013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1332    0.3262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  3  1  0
  5  4  2  0
  6  5  1  0
  1  6  2  0
  7  2  1  0
  8  7  1  0
  8  9  2  0
 10  8  1  1
 10 11  1  0
 11 12  1  6
 11 13  1  0
 14 13  1  0
 14 15  1  6
 14 16  1  0
 16 17  1  0
 17 11  1  0
 18 14  1  0
 18 10  1  0
 18 19  1  1
 20 18  1  0
 20 21  2  0
 21 22  1  0
 22 10  1  0
 20 23  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 23 28  1  0
  1 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5195876

    ---

Associated Targets(Human)

CYP11B2 Tchem Cytochrome P450 11B2 (2325 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP11B1 Tclin Cytochrome P450 11B1 (1750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.42Molecular Weight (Monoisotopic): 347.1634AlogP: 3.55#Rotatable Bonds: 3
Polar Surface Area: 63.58Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.74CX Basic pKa: 4.21CX LogP: 3.50CX LogD: 3.50
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.92Np Likeness Score: -0.33

References

1. Yin L, Pan Y, Xue Y, Chen X, You T, Huang J, Xu Q, Hu Q..  (2022)  Design, Synthesis, and Biological Evaluations of Pyridyl 4,5,6,7-Tetrahydro-4,7-Methanobenzo[d]isoxazoles as Potent and Selective Inhibitors of 11β-Hydroxylase.,  65  (17.0): [PMID:35975976] [10.1021/acs.jmedchem.2c01037]

Source